Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders
A Standard patent application filed on 08 May 2002 credited to Mott, Andrew ; Jensen, Annika ; Johansson, Gary ; Bremberg, Ulf ; Sutin, Lori ; Caldirola, Patrizia ; Tejbrant, Jan

Details

Application number :

2002303061  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Novel, arylsulfonamide compounds for the treatment of obesity, type II diabetes and CNS-disorders  

Inventor :

Mott, Andrew ; Jensen, Annika ; Johansson, Gary ; Bremberg, Ulf ; Sutin, Lori ; Caldirola, Patrizia ; Tejbrant, Jan  

Agent name :

Davies Collison Cave  

Address for service :

1 Nicholson Street Melbourne VIC 3000 Australia  

Filing date :

08 May 2002  

Associated companies :

 

Applicant name :

Biovitrum AB (publ)  

Applicant address :

S-112 76 Stockholm Sweden  

Old name :

Biovitrum AB  

Original Source :

Go